Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 6 (2009), Issue 1 (January)

1. A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients.
   Cancer Res, 69(1): 120-7. [Abstract] [Full-text]
2. NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas.
   PLoS ONE, 4(1): e4107. [Abstract] [Full-text]
3. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
   J Neurosurg Pediatrics, 3(1): 61-5. [Abstract] [Full-text]
4. Aggressive variant of a papillary glioneuronal tumor. Report of 2 cases.
   J Neurosurg Pediatrics, 3(1): 46-52. [Abstract] [Full-text]
5. Tentorial cavernous angioma with profuse bleeding. Case report.
   J Neurosurg Pediatrics, 3(1): 37-40. [Abstract] [Full-text]
6. Primary mixed glioneuronal tumor of the central nervous system in a patient with noonan syndrome: a case report and review of the literature.
   J Pediatr Hematol Oncol, 31(1): 61-4. [Abstract] [Full-text]
7. Clinical nurse coordinators: a new generation of highly specialized oncology nursing in Jordan.
   J Pediatr Hematol Oncol, 31(1): 38-41. [Abstract] [Full-text]
8. Ruptured intracranial dermoid cyst presenting with neuropsychiatric symptoms: a case report.
   South Med J, 102(1): 98-100. [Abstract] [Full-text]
9. Gamma Knife stereotactic radiosurgery for intracranial metastases from conventionally radioresistant primary cancers: outcome analysis of survival and control of brain disease.
   South Med J, 102(1): 42-4. [Abstract] [Full-text]
10. LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model.
    Br J Cancer, 100(1): 106-12. [Abstract] [Full-text]
11. cDNA clone, prokaryotic expression and purification of human interleukin-13 receptor [alpha]2 chain.
    Cancer Immunol Immunother, 58(3): 409-13. [Abstract] [Full-text]
12. Using gene expression profiling to identify a prognostic molecular spectrum in gliomas.
    Cancer Sci, 100(1): 165-72. [Abstract] [Full-text]
13. Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example.
    Hum Pathol, 40(2): 270-8. [Abstract] [Full-text]
14. alpha-Internexin expression identifies 1p19q codeleted gliomas.
    Neurology, 72(2): 156-61. [Abstract] [Full-text]
15. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
    Am J Clin Pathol, 131(2): 257-63. [Abstract] [Full-text]
16. A mathematical model for brain tumor response to radiation therapy.
    J Math Biol, 58(4): 561-78. [Abstract] [Full-text]
17. A color-coded orthotopic nude-mouse treatment model of brain-metastatic paralyzing spinal cord cancer that induces angiogenesis and neurogenesis.
    Cell Prolif, 42(1): 75-82. [Abstract] [Full-text]
18. Clinical experiences with onboard imager KV images for linear accelerator-based stereotactic radiosurgery and radiotherapy setup.
    Int J Radiat Oncol Biol Phys, 73(2): 556-61. [Abstract] [Full-text]
19. Optimization of isocenter location for intensity modulated stereotactic treatment of small intracranial targets.
    Int J Radiat Oncol Biol Phys, 73(2): 546-55. [Abstract] [Full-text]
20. Efficacy of intracerebral delivery of Carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats.
    Int J Radiat Oncol Biol Phys, 73(2): 530-6. [Abstract] [Full-text]
21. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
    Int J Radiat Oncol Biol Phys, 73(2): 486-91. [Abstract] [Full-text]
22. Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.
    Int J Radiat Oncol Biol Phys, 73(2): 479-85. [Abstract] [Full-text]
23. Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator.
    Int J Radiat Oncol Biol Phys, 73(2): 562-70. [Abstract] [Full-text]
24. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
    Int J Radiat Oncol Biol Phys, 73(2): 473-8. [Abstract] [Full-text]
25. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas.
    Cancer Res, 69(2): 458-65. [Abstract] [Full-text]
26. p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
    Cancer Res, 69(2): 440-8. [Abstract] [Full-text]
27. De novo induction of genetically engineered brain tumors in mice using plasmid DNA.
    Cancer Res, 69(2): 431-9. [Abstract] [Full-text]
28. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.
    J Clin Oncol, 27(3): 385-9. [Abstract] [Full-text]
29. Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy.
    Int J Cancer, 124(6): 1293-300. [Abstract] [Full-text]
30. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
    AJR Am J Roentgenol, 192(2): W45-52. [Abstract] [Full-text]
31. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas.
    Pathol Int, 59(2): 80-5. [Abstract] [Full-text]
32. Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker.
    Neuropathology, 29(1): 40-4. [Abstract] [Full-text]
33. Glioneuronal tumor with neuropil-like islands: a new entity.
    Neuropathology, 29(1): 96-100. [Abstract] [Full-text]
34. GFAPdelta immunostaining improves visualization of normal and pathologic astrocytic heterogeneity.
    Neuropathology, 29(1): 31-9. [Abstract] [Full-text]
35. Folliculostellate cell tumor in pituitary gland.
    Neuropathology, 29(1): 78-80. [Abstract] [Full-text]
36. Spherical amyloid deposition in a prolactin-producing pituitary adenoma.
    Neuropathology, 29(1): 81-4. [Abstract] [Full-text]
37. Chordoid glioma of the third ventricle: a report of two cases, one with ultrastructural findings.
    Neuropathology, 29(1): 85-90. [Abstract] [Full-text]
38. Melanocytic medulloblastoma with ganglioneurocytomatous differentiation: a case report.
    Neuropathology, 29(1): 72-7. [Abstract] [Full-text]
39. Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface.
    Pigment Cell Melanoma Res, 22(1): 86-98. [Abstract] [Full-text]
40. NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors.
    Oncogene, 28(3): 378-89. [Abstract] [Full-text]
41. Polymeric drugs based on bioactive glycosides for the treatment of brain tumours.
    Biomaterials, 30(8): 1613-26. [Abstract] [Full-text]
42. Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor.
    Am J Surg Pathol, 33(2): 211-7. [Abstract] [Full-text]
43. Dosimetric comparison of conventional helmet-field whole-brain irradiation with three-dimensional conformal radiotherapy: dose homogeneity and retro-orbital area coverage.
    Br J Radiol, 82(974): 118-22. [Abstract] [Full-text]
44. Predictors of short-term outcomes following endoscopic pituitary surgery.
    Clin Neurol Neurosurg, 111(2): 119-22. [Abstract] [Full-text]
45. Pregabalin in patients with primary brain tumors and seizures: a preliminary observation.
    Clin Neurol Neurosurg, 111(2): 171-3. [Abstract] [Full-text]
46. Duane retraction syndrome, nystagmus, retinal pigment epitheliopathy and epiretinal membrane with micro- and pachygyria, developmental delay, hearing loss and craniopharyngioma.
    Ophthalmic Genet, 30(1): 7-12. [Abstract] [Full-text]
47. Treatment planning for a synchrotron-based radiotherapy modality.
    Appl Radiat Isot, 67(3): 492-4. [Abstract] [Full-text]
48. BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line.
    Cancer Chemother Pharmacol, 63(4): 753-8. [Abstract] [Full-text]
49. Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes?
    Cancer Chemother Pharmacol, 63(4): 627-33. [Abstract] [Full-text]
50. Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis.
    Oncogene, 28(4): 500-8. [Abstract] [Full-text]
51. Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway.
    Oncogene, 28(4): 492-9. [Abstract] [Full-text]
52. Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy.
    Cancer Treat Rev, 35(1): 79-96. [Abstract] [Full-text]

© 2004-2010 Brain Tumors Research Today. All Rights Reserved.